Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

Dr. Atlal Abusanad discusses how biases in valuing capability and potential in female oncologists has led to their underrepresentation in prominent roles. 
ASCO’s delegation to the American Medical Association (AMA) recently met virtually with the AMA’s House of Delegates (HOD), with a focus on payment reform models. 
Despite the virtual nature of the AMA House of Delegates meeting, the decisions made there have a very real impact on our profession and the patients we serve.
My colleague and friend Ginny Mason and I discuss advocacy, "beating the odds," and her perspective 26 years out from an initial diagnosis of inflammatory breast cancer.
ASCO president Dr. Lori J. Pierce and I discuss her background, her presidential theme, and ASCO efforts related to health equity and representation.
Although our societal meetings, including the AMA House of Delegates meeting, are shortened, they have never been more important than they are at this moment.
A spirit of clinically relevant discovery and accessible, understandable knowledge dissemination is the profound legacy, responsibility, and obligation that Rich will leave at ASCO, and we will honor him by continuing this work at the level of rigor and quality he established.
We must commit the same energy and focus we pour into conquering cancer to addressing systemic issues that affect the health of people of color in our country.
Dr. Ray Page and I discuss the important role that drug repository programs can play in helping our patients afford their treatment while reducing the financial toll on the cancer care delivery system.
At a time when every physician is needed, U.S. visa restrictions on international medical graduates are making it impossible for them to do the most good, writes Dr. Sreekanth Donepudi. 
Jennifer Merschdorf of Young Survival Coalition and I discuss how she brings her business experience to the social-profit space and the value of partnerships in advocacy.
Dr. Jason Westin explains the science behind the transformative CAR T-cell therapy, and the financial concern it presents to our health care system and our patients.
ASCO's chief medical officer Dr. Richard L. Schilsky and I discuss the refinement of cancer surgery, the critical importance of federally funded research, and ASCO's research priorities for the oncology community.
"Quality improvement happens slowly if you're in a silo": Dr. Jeffery Ward and I discuss the important updates to ASCO's alternative payment model for high-quality oncology care.
As we begin our work in 2020, I am excited that we are building on the remarkable successes of 2019, and the years before, with growing collaboration and sharpening focus. 
Wherever we live, whatever we do for our day jobs, we have a responsibility to be politically aware and politically engaged.
ASCO's delegation to the AMA HOD invites all ASCO members to share their thoughts and concerns concerning issues affecting the practice of oncology, as your input directly impacts the delegation's work.
Participants in ASCO's Advocacy Summit discuss the importance of being engaged with health policy to improve the lives of people affected by cancer.

Pages


Advertisement